SCN11A
protein-codingsodium voltage-gated channel alpha subunit 11, the group of Sodium voltage-gated channel alpha subunits
Gene summary
Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is highly expressed in nociceptive neurons of dorsal root ganglia and trigeminal ganglia. It mediates brain-derived neurotrophic factor-evoked membrane depolarization and is a major effector of peripheral inflammatory pain hypersensitivity. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy type VII and familial episodic pain syndrome-3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]
- SCN12A
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~206.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014247
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014244
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014247
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014244
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014247
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014244
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014244
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014244
Submitter: ClinGen
The gene SCN11A encodes the voltage-gated sodium channel Nav1.9 that was first discovered to be expressed in sensory neurons in 1998 (PMID: 9671787). Together with other voltage-gated sodium channel genes (SCN9A, SCN10A), likewise associated with hereditary neuropathic pain syndromes, it is responsible for the generation of action potentials in nociceptive nerve fibers (PMID: 27556810). In 2013, Leipold et al. (PMID: 24036948) described two families with the same de-novo SCN11A missense variant in association with congenital insensitivity to pain. Both affected individuals showed severe self-mutilation and autonomic disturbances. This phenotype was reproduced in patients with the same (PMIDs: 30395542, 25118027) and two different (PMIDs: 28289907, 26746779) SCN11A missense variants, all located in the terminal segment of one of the transmembrane domains (S6) constituting the pore-forming part of the sodium channel (PMIDs: 32601768, 28289907). By patch-clamp analysis, variants were shown to results in a prominent gain-of-function phenotype mediated by a leftward shift in channel activation and deactivation kinetics as well as by a slow- down in channel inactivation. A reduced density of spontaneous synaptic events in mouse dorsal horn neurons from a respective mouse model was observed (PMID: 24036948). In a heterozygous knock-in mouse model, the patient phenotype was reproduced showing non-healing wounds, increased amounts of scratch-bouts, and reduced grip-strength (PMIDs: 24036948, 32817686). In parallel, SCN11A has also been reported in association with an autosomal dominant neuropathic pain disorder described as recurrent episodes of severe distal limb and facial pain responding to NSAIDs and being aggravated by cold. Heterozygous missense mutations were found to segregate in large families (PMIDs: 24207120, 28298626, 30046661). On functional level, the variants increased current densities, but did not change the channel’s activation or deactivation thresholds (PMIDs: 24207120). In a heterozygous knock-in mouse model, the phenotype reproduced the phenomenon of cold-aggravated allodynia (PMID: 32970203). We therefore conclude that heterozygous missense mutations in SCN11A can cause both loss and gain of pain, depending on the respective consequences on cellular level. In other neuropathic pain disorder such as small fiber neuropathies, screening studies revealed the presence of SCN11A variants in several unrelated cases (PMID: 24776970). Despite causing a gain of channel function in voltage-clamp analyses, these variants show a variable allele frequency in control populations. It is therefore unclear to date, to what extent they constitute risk factors or contribute to the phenotype. In summary, the panel concludes that the gene disease relationship for SCN11A and autosomal dominant hereditary sensory and autonomic neuropathy is definitive. Of note, yet no clear pathological or electrophysiological signs of neuropathy have been reported in these pain perception disorders. Considering the expression in nociceptive sensory neurons and their expected dysfunction, however, the panel decided to call this disease “neuropathy”.
Inheritance Pattern: AD
Disease ID:MONDO:0017629
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: The pain has been reported as responsive to oral anti-inflammatory analgesics; Congenital insensitivity to pain can result in injuries and infections
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SCN11A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001349253.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 18 | 300 | 9 | 327 | ||
| missense | 4 | 6 | 850 | 104 | 4 | 968 |
| nonsense | 1 | 36 | 1 | 38 | ||
| start loss | 1 | 1 | ||||
| frameshift | 52 | 1 | 53 | |||
| splice donor/acceptor (+/-2bp) | 24 | 24 | ||||
| Total | 4 | 7 | 981 | 406 | 13 | 1411 |
Highest pathogenic variant AF is 0.000022574413
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001336182.1 | 26 | MANE Select | |
| Ensembl | ENSP00000307599.3 | 26 | MANE Select | |
| RefSeq | NP_054858.2 | 26 | Standard | |
| Ensembl | ENSP00000408028.2 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Developmental Biology
- Phase 0 - rapid depolarisation
- Cardiac conduction
- Muscle contraction
- Interaction between L1 and Ankyrins
Biological Process
- sodium ion transport
- neuronal action potential
- regulation of ion transmembrane transport
- sodium ion transmembrane transport
- response to drug
Molecular Function
- voltage-gated ion channel activity
- voltage-gated sodium channel activity
Cellular Component
- voltage-gated sodium channel complex
- plasma membrane
- axon
- C-fiber
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000302328
- Coding exons
- 26
- Length
- 104793
- Individuals with no LoFs
- 125517
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 231
- Defined
- 125748
- p
- 0.000919
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.964 | 881 | 965 | 0.913 | 0.0000517 | 11927 |
| Missense (PolyPhen) | 324 | 422.06 | 0.76765 | 5339 | ||
| Synonymous | -0.249 | 350 | 344 | 1.02 | 0.0000186 | 3317 |
| Loss of Function | 2.84 | 53 | 80.5 | 0.659 | 0.00000451 | 933 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00086 | 0.00086 | rare |
| Latino/Admixed American | 0.0018 | 0.0017 | notable |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00039 | 0.00038 | rare |
| Finnish | 0.00060 | 0.00060 | rare |
| European (Non-Finnish) | 0.0011 | 0.00098 | notable |
| South Asian | 0.00085 | 0.00059 | rare |
| Other | 0.0012 | 0.0011 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: This protein mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. It is a tetrodotoxin-resistant sodium channel isoform. Also involved, with the contribution of the receptor tyrosine kinase NTRK2, in rapid BDNF-evoked neuronal depolarization. {ECO:0000269|PubMed:10580103, ECO:0000269|PubMed:12384689}.;
- Disease
- DISEASE: Neuropathy, hereditary sensory and autonomic, 7 (HSAN7) [MIM:615548]: A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN7 is characterized by congenital inability to experience pain resulting in self-mutilations, slow-healing wounds, and multiple painless fractures. mild muscle weakness, delayed motor development, slightly reduced motor and sensory nerve conduction velocities, hyperhidrosis and gastrointestinal dysfunction. {ECO:0000269|PubMed:24036948, ECO:0000269|PubMed:26645915}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Episodic pain syndrome, familial, 3 (FEPS3) [MIM:615552]: An autosomal dominant neurologic disorder characterized by paroxysmal pain mainly affecting the distal lower extremities and occasionally the upper body, especially the joints of fingers and arms. The pain is exacerbated with fatigue. {ECO:0000269|PubMed:24207120, ECO:0000269|PubMed:24776970, ECO:0000269|PubMed:25791876, ECO:0000269|PubMed:27224030}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.0774
- RVIS EVS
- -1.82
- RVIS percentile EVS
- 2.14
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.135
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |